SCHEMBL25952507

SCHEMBL25952507

COCOc1c(C)c(O)c(C(=O)/C=C/c2ccc(O)cc2)c(OC)c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.61
▸ BACE1 P56817 3/20 0.49
▸ KCNA3 P22001 2/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ PDPK1 O15530 1/20 0.47
▸ TTR P02766 1/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ NFKB1 P19838 3/20 0.46
▸ NFKB2 Q00653 3/20 0.46
▸ RELA Q04206 3/20 0.46
▸ DPP4 P27487 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ P4HB P07237 1/20 0.45
▸ CALM1 P0DP23 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25952454 0.93 ABCB1 (0.61) ABCB1BACE1KCNA3MAPTALDH1A1
SCHEMBL25339313 0.93 ABCB1 (0.61) ABCB1BACE1KCNA3MAPTALDH1A1
SCHEMBL25952460 0.92 ABCB1 (0.60) ABCB1KCNA3MAPTALDH1A1LMNA
SCHEMBL25339626 0.92 ABCB1 (0.60) ABCB1KCNA3MAPTALDH1A1LMNA
SCHEMBL25952463 0.92 ABCB1 (0.60) ABCB1KCNA3MAPTALDH1A1LMNA
SCHEMBL25342585 0.92 ABCB1 (0.60) ABCB1KCNA3MAPTALDH1A1LMNA
SCHEMBL25341084 0.91 ABCB1 (0.59) ABCB1BACE1KCNA3MAPTALDH1A1
SCHEMBL25429661 0.91 ABCB1 (0.59) ABCB1KCNA3MAPTALDH1A1LMNA
SCHEMBL25952448 0.91 ABCB1 (0.59) ABCB1BACE1KCNA3MAPTALDH1A1
SCHEMBL25952401 0.91 ABCB1 (0.59) ABCB1KCNA3MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE LIPC, PC, CYP27A1 ABCB1 3180/4885BACE1 1678/4885KCNA3 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback